Shaun Kai Kiat Chua

Mr. Shaun Kai Kiat Chua


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2024 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
SCShaun Kai Kiat Chua
Shaun Kai Kiat Chua
CLChien Joo Msc Lim
Chien Joo Msc Lim
YPYonghao Pua
Yonghao Pua
SYSu-Yin PhD (CPsychol) Yang
Su-Yin PhD (CPsychol) Yang
BTBryan Tan
Bryan Tan
Background: Beyond knee pain itself, the fear of movement, also known as kinesiophobia, recently has been proposed as a potential factor contributing to disability and functional limitation in patients with knee osteoarthritis (OA). Nevertheless, the available evidence on the association of kinesiophobia with patient-reported outcome measures (PROMs) in knee OA remains limited. Questions/purposes: Among patients with nonoperatively treated knee OA, we asked: (1) Is kinesiophobia associated with decreased quality of life (QoL), functional outcomes, and physical activity? (2) What are the patient disease and psychosocial demographic factors associated with kinesiophobia? Methods: This was a multicenter, cross-sectional study of 406 general orthopaedic patients from two urban, referral-based tertiary hospitals in Singapore under a single healthcare group who received nonoperative treatment for knee OA. Between July 2020 and January 2022, a total of 1541 patients were treated for knee OA nonoperatively. Based on that, 60% (923) of patients were rejected due to refusal to participate in the study, 3% (52) of patients were enrolled but did not show up for their appointments for data collection, and a further 10% (160) had incomplete data sets, leaving 26% (406) for this study’s analysis. The mean age of patients was 64 ± 8 years, 69% were women, and 81% were Chinese. The level of kinesiophobia in patients was measured using the Brief Fear of Movement scale, a validated 6-item questionnaire ranging from a score of 6 to 24 to measure kinesiophobia in OA, with higher scores representing higher levels of kinesiophobia. In terms of PROMs, the QoL and functional level of patients were measured using the QoL and activities of daily living (ADL) components of the widely validated 12-item Knee Injury and Osteoarthritis Outcome Score (KOOS-12). The KOOS-12 is a questionnaire consisting of 12 items encompassing three domains (QoL, ADL, and pain), with each item ranging from 0 to 4 and higher scores representing worse outcomes. The University of California, Los Angeles (UCLA) Activity Scale was used to measure the level of physical activity in patients. The UCLA score is a descriptive 10-level activity scale ranging from a score of 1 to 10, with higher scores representing greater physical activity levels. A directed acyclic graph, which is a relationship map used to depict and visualize the confounders between the studied variables, was used to identify the confounders between kinesiophobia and PROMs (QoL, function, and physical activity). An ordinal regression model was used to explore: (1) the association between kinesiophobia (as measured using the Brief Fear of Movement scale) and PROMs (as measured using KOOS QoL, KOOS ADL, and the UCLA Activity Scale), adjusting for key confounders such as age, gender, pain, side of arthritis, OA duration/severity, and psychosocial factors (for example, depression, anxiety, and education levels), and (2) the association between kinesiophobia (Brief Fear of Movement scale) and various patient disease and psychosocial demographic factors. Results: After accounting for confounders, greater kinesiophobia (higher Brief Fear of Movement scores) was associated with lower QoL (KOOS QoL score adjusted IQR OR 0.69 [95% confidence interval (CI) 0.53 to 0.90]; p = 0.007) and lower physical activity (UCLA score adjusted IQR OR 0.68 [95% CI 0.52 to 0.90]; p = 0.007); however, there was no association between kinesiophobia and function (KOOS ADL score adjusted IQR OR 0.90 [95% CI 0.70 to 1.17]; p = 0.45). After adjusting for age, gender, OA duration, pain, and BMI, higher levels of anxiety (Patient Health Questionnaire 2 [PHQ-2] anxiety score adjusted OR 2.49 [95% CI 1.36 to 4.58]; p = 0.003) and depression (PHQ-2 depression score adjusted OR 3.38 [95% CI 1.73 to 6.62]; p < 0.001) were associated with higher levels of kinesiophobia. Education level, OA disease severity, side of arthritis (unilateral versus bilateral), and history of previous injury or surgery on the knee were not associated with kinesiophobia. Conclusion: Clinicians should assess for kinesiophobia and other psychological comorbidities such as depression and anxiety at the point of initial evaluation and subsequent follow-up of knee OA with simple validated tools like the Brief Fear of Movement scale (kinesiophobia) in the clinic. This allows for clinicians to identify high-risk individuals and offer evidence-based treatment such as cognitive behavioral therapies with a multidisciplinary team, including a physical therapist and psychologist, to manage these psychological comorbidities and improve outcomes in patients with knee OA. While kinesiophobia was found to be associated with poorer QoL and physical activity, future studies including larger observational cohort studies should be conducted to determine causal and prognostic relationships between kinesiophobia and outcomes in knee OA. Level of Evidence: Level III, prognostic study.

30 May 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
SCShaun Kai Kiat Chua
Shaun Kai Kiat Chua
QSQian Ying Soh
Qian Ying Soh
Seyed Ehsan SaffariSeyed Ehsan Saffari
Seyed Ehsan Saffari
Eng King TanEng King Tan
Eng King Tan
There have been increasing reports of Guillain–Barré syndrome (GBS), a rare but debilitating neurological disease, occurring post-COVID-19 vaccination. However, the outcomes and relationships between patient demographics and clinical outcomes of post-COVID-19 vaccination GBS remain unclear. To bridge this gap, our study investigates the outcomes and clinical factors associated with poorer GBS outcomes following COVID-19 vaccination. We conducted a review and pooled analysis of detailed data extracted from 57 published cases with the relevant search strategies and criteria. The groups compared included male versus female patients, 1st dose versus 2nd dose and early onset versus late onset of GBS. Multivariate regression analysis was performed to compare the vaccine type, clinical severity and post-treatment outcomes between these groups of patients. Our results highlight for the first time that females were significantly more likely to have severe clinical presentation and poorer outcomes compared to males. Additionally, viral vector vaccines were the predominant vaccine type administered in early-onset post-COVID-19-vaccination GBS and GBS occurring after the 1st vaccination dose. It was also shown that reported cases of post-vaccination GBS generally displayed a positive response to conventional treatment and had favourable post-treatment outcomes. Through this study, we have established important links and provided assuring evidence for treatment response and post-treatment outcomes of GBS occurring post-COVID-19 vaccination. While the COVID-19 vaccination brings about much greater benefits than risks, our findings provide further impetus for greater vigilance in certain patient groups and more studies to explore the mechanisms behind these links.

16 April 2024 in CARTILAGE
Verified
Journal Article
Open access
SCShaun Kai Kiat Chua
Shaun Kai Kiat Chua
WWWalter-Soon-Yaw Wong
Walter-Soon-Yaw Wong
DKDon Thong Siang Koh
Don Thong Siang Koh
RSRehena Sultana
Rehena Sultana
JSJunwei Soong
Junwei Soong
HRHamid Rahmatullah Bin Abd Razak
Hamid Rahmatullah Bin Abd Razak
Objective: The use of synthetic bone substitute material (BSM) as osteotomy gap fillers have been reported to improve outcomes in medial opening wedge high tibial osteotomy (MOWHTO). This study aims to evaluate the early radiological outcomes (bone union) and complication rates of the novel patient-specific 3D-printed honeycomb-structured polycaprolactone and tricalcium phosphate (PCL-TCP) synthetic graft compared to allogeneic bone grafts as an osteotomy gap filler in MOWHTO. Methods: A retrospective matched-pair analysis of patients who underwent MOWHTO with either PCL-TCP synthetic graft or allogenic femoral head allograft as osteotomy gap filler was performed. The osteotomy gap was split into equal zones (Zone 1-5), and bone union was evaluated on anteroposterior radiographs based on the van Hemert classification at 1, 3, 6, and 12 months postoperatively. Postoperative complications including infection, lateral hinge fractures, and persistent pain was measured. The study and control group were matched for age, smoking status, diabetes mellitus, and osteotomy gap size. Results: Significantly greater bone union progression was observed in the PCL-TCP group than in the allograft group at 1 month (Zones 1-3), 3 months (Zones 1-4), 6 months (Zones 1-2, 4), and 12 months (Zones 2-3, 5) postoperatively ( P < 0.05). No significant difference in complications rates was noted between the two groups at 1 year. Conclusions: Bone union rates observed in patients who underwent MOWHTO with the PCL-TCP synthetic graft osteotomy gap filler were superior to those in the allograft group at 1 year postoperatively, with no significant difference in complication rates (postoperative infection, lateral hinge fractures, and persistent pain).


30 September 2025 in Annals of the Academy of Medicine, Singapore
Verified
Journal Article
Open access
SCShaun Kai Kiat Chua
Shaun Kai Kiat Chua
NLNoah Tian Run Lim
Noah Tian Run Lim
ATAnna Hien Anh Tran
Anna Hien Anh Tran
LSLiang Shen
Liang Shen
CHChoon Chiet Hong
Choon Chiet Hong
JTJonathan Jiong Hao Tan
Jonathan Jiong Hao Tan
Necrotising fasciitis (NF) is a rapidly progressive infection that spreads across the fascial planes, leading to tissue necrosis and severe systemic toxicity.1 In Singapore, Wong et al. conducted a retrospective study on a cohort of 89 patients in 2004 and found that the misdiagnosis rate was 85%, amputation rate was 23% and mortality rate was 21%.2,3 However, since these early studies, there has been a paucity of data on NF in the Singapore context, despite changing antimicrobial resistance patterns and evolving management approaches.2,3 To address this gap, a 17-year retrospective cohort study was conducted in the National University Hospital (NUH) in Singapore. The aim was to report an update of the clinical/microbiological profile, adverse outcomes (amputation/mortality) rates and identify predictive factors for adverse outcomes in patients with extremity NF.

29 June 2026 in Journal of Patient-Reported Outcomes
Verified
Journal Article
Open access
PDF file
SCShaun Kai Kiat Chua
Shaun Kai Kiat Chua
LTLinus Ren Hao Tan
Linus Ren Hao Tan
CLChien Joo Lim
Chien Joo Lim
MPMichelle Jessica Pereira
Michelle Jessica Pereira
BTBryan Tan
Bryan Tan
Background: Significant heterogeneity exists in the patient-reported outcome measures (PROMs) used to assess outcomes in knee osteoarthritis (KOA), with limited evidence exploring the correlation and conversion among the various PROMs. Our study aims to explore the correlation and conversion between the Oxford Knee Score (OKS), Knee Injury and Osteoarthritis Outcome Score (KOOS-12) and Knee Society Score (KSS) in patients with non-operatively treated KOA. Methodology: This was a prospective cohort study of 131 patients who received non-operative treatment (standardized physical therapy and analgesia) for KOA between July 2020 and January 2024. Three validated PROMs for KOA (OKS, KOOS-12 and KSS) were measured for patients at baseline, 3-months, 6-months, 1-year and 2-years follow-up. Overall, 498 complete paired outcome scores (KSS/OKS/KOOS-12 at a single time point) were included for analysis. The data were then randomly split into a derivation (75%) and internal validation (25%) cohort. The correlation between the outcome scores were calculated, and linear regression model was used to obtain conversion equations between the measured outcomes. Internal validation of the derived conversion equation was performed subsequently by comparing the mean difference between the equation-derived and actual scores. Results: A significant strong positive correlation was found between KOOS-12 and OKS (coefficient:0.79; p < 0.001), and a significant moderate positive correlation was found between the KOOS-12 and KSS (coefficient:0.50; p < 0.001). A significant moderate positive correlation was found between the OKS and KSS (coefficient:0.67; p < 0.001). Six conversion equations derived for the measured PROMs had low mean difference between the equation-derived and actual scores (0.31–1.68). Moderate to strong correlation was found between the actual and equation-derived scores, with weakest strength observed in the conversion between KOOS-12 and KSS (coefficient:0.53) and the strongest strength observed in the conversion between KOOS-12 and OKS (coefficient:0.80). Conclusions: On internal validation, we found good correlation between the mean actual and equation-derived outcome scores despite significant within-individual variability. The conversion equations derived in this study can facilitate pooling and comparison of studies using heterogenous outcomes measures and meta-analysis to increase statistical power and address novel questions in KOA. Nonetheless, the equations should not be utilized to predict individual scores from one to another due to high within-individual variability. Clinical trial number: Not applicable.